{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T10:03:20Z","timestamp":1771236200077,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:00:00Z","timestamp":1625875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:00:00Z","timestamp":1625875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["RVO 00023728"],"award-info":[{"award-number":["RVO 00023728"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["RVO VFN64165"],"award-info":[{"award-number":["RVO VFN64165"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["BBMRI-CZ LM2018125"],"award-info":[{"award-number":["BBMRI-CZ LM2018125"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["SVV 260367 UK"],"award-info":[{"award-number":["SVV 260367 UK"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>MicroRNAs (miRNAs) are short single-stranded RNAs that play a role in the post-transcriptional regulation of gene expression. Their deregulation can be associated with various diseases, such as cancer, neurodegenerative, and immune-related diseases. The aim of our study was to compare miRNA levels in plasma that could potentially influence the progression of hyperuricemia to gout, since the mechanism of progression is still unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Total RNA, including miRNA, was isolated from the plasma of 45 patients with asymptomatic hyperuricemia, 131 patients with primary gout (including 16 patients having a gout attack), and 130 normouricemic controls. The expression of 18 selected miRNAs (cel-miR-39 and cel-miR-54 as spike-in controls, hsa-miR-16-5p and hsa-miR-25-3p as endogenous controls, hsa-miR-17-5p, hsa-miR-18a-5p, hsa-miR-30a-3p, hsa-miR-30c-5p, hsa-miR-126-3p, hsa-miR-133a-3p, hsa-miR-142-3p, hsa-miR-143-3p, hsa-miR-146a-5p, hsa-miR-155-5p, hsa-miR-222-3p, hsa-miR-223-3p, hsa-miR-488-3p and hsa-miR-920) was measured using qPCR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found that hsa-miR-17-5p, hsa-miR-18a-5p, hsa-miR-30c-5p, hsa-miR-142-3p, and hsa-miR-223-3p were significantly upregulated (<jats:italic>p<\/jats:italic>&lt;\u20090.001) in the plasma of hyperuricemia and gout patients compared to normouricemic individuals. As part of the follow-up of our previous study, we found a negative correlation between hsa-miR-17-5p, hsa-miR-30c-5p, hsa-miR-126-3p, hsa-miR-142-3p, and hsa-miR-223-3p with plasma levels of chemokine MCP-1. Additionally, we found a positive correlation between CRP and plasma levels of hsa-miR-17-5p, hsa-miR-18a-5p, hsa-miR-30c-5p, hsa-miR-126-3p, hsa-miR-142-3p, hsa-miR-146a-5p, hsa-miR-155-5p, hsa-miR-222-3p, and hsa-miR-223-3p. Five of those miRNAs (hsa-miR-126-3p, hsa-miR-142-3p, hsa-miR-146a-5p, hsa-miR-155-5p, and hsa-miR-222-3p) also had a positive correlation with serum creatinine and therefore a negative correlation with eGFR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Five miRNAs were significantly upregulated in the plasma of patients with hyperuricemia and gout (and those during a gout attack) compared to normouricemic controls. We also found a correlation between the plasma levels of several miRNA and plasma levels of MCP-1, CRP, serum creatinine, and eGFR.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13075-021-02569-w","type":"journal-article","created":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T04:02:36Z","timestamp":1625889756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Circulating microRNA alternations in primary hyperuricemia and gout"],"prefix":"10.1186","volume":"23","author":[{"given":"Jana","family":"Bohat\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Horv\u00e1thov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark\u00e9ta","family":"Pavl\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanka","family":"Stib\u016frkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,10]]},"reference":[{"key":"2569_CR1","doi-asserted-by":"publisher","unstructured":"Hurba O, Mancikova A, Krylov V, Pavlikova M, Pavelka K, Stib\u016frkov\u00e1 B. Complex analysis of urate Transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout. PLoS One. 2014;9. https:\/\/doi.org\/10.1371\/journal.pone.0107902.","DOI":"10.1371\/journal.pone.0107902"},{"key":"2569_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/srep02014","volume":"3","author":"H Matsuo","year":"2013","unstructured":"Matsuo H, Ichida K, Takada T, Nakayama A, Nakashima H, Nakamura T, et al. Common dysfunctional variants in ABCG2 are a major cause of early-onset gout. Sci Rep. 2013;3:8\u201311. https:\/\/doi.org\/10.1038\/srep02014.","journal-title":"Sci Rep."},{"key":"2569_CR3","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/kex295","volume":"56","author":"B Stiburkova","year":"2017","unstructured":"Stiburkova B, Pavelcova K, Zavada J, Petru L, Simek P, Cepek P, et al. Functional non-synonymous variants of ABCG2 and gout risk. Rheumatol (United Kingdom). 2017;56:1982\u201392. https:\/\/doi.org\/10.1093\/rheumatology\/kex295.","journal-title":"Rheumatol (United Kingdom)"},{"key":"2569_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13075-019-2007-7","volume":"21","author":"Y Toyoda","year":"2019","unstructured":"Toyoda Y, Pavelcov\u00e1 K, Klein M, Suzuki H, Takada T, Stiburkova B. Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2. Arthritis Res Ther. 2019;21:219. https:\/\/doi.org\/10.1186\/s13075-019-2007-7.","journal-title":"Arthritis Res Ther."},{"key":"2569_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1759720X15599734","volume":"7","author":"F Perez-Ruiz","year":"2015","unstructured":"Perez-Ruiz F, Marimon E, Chinchilla SP. Hyperuricaemia with deposition: latest evidence and therapeutic approach. Ther Adv Musculoskelet Dis. 2015;7:225\u201333. https:\/\/doi.org\/10.1177\/1759720X15599734.","journal-title":"Ther Adv Musculoskelet Dis."},{"key":"2569_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","volume":"5","author":"N Dalbeth","year":"2019","unstructured":"Dalbeth N, Choi HK, Joosten LAB, Khanna PP, Matsuo H, Perez-Ruiz F, et al. Gout. Nat Rev Dis Prim. 2019;5:69. https:\/\/doi.org\/10.1038\/s41572-019-0115-y.","journal-title":"Nat Rev Dis Prim."},{"key":"2569_CR7","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1136\/annrheumdis-2019-215521","volume":"78","author":"Y Kawamura","year":"2019","unstructured":"Kawamura Y, Nakaoka H, Nakayama A, Okada Y, Yamamoto K, Higashino T, et al. Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout. Ann Rheum Dis. 2019;78:1430\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215521.","journal-title":"Ann Rheum Dis."},{"key":"2569_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843\u201354. https:\/\/doi.org\/10.1016\/0092-8674(93)90529-y.","journal-title":"Cell."},{"key":"2569_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/ijms22020542","volume":"10","author":"MH Sohel","year":"2016","unstructured":"Sohel MH. Extracellular\/Circulating MicroRNAs: Release Mechanisms, Functions and Challenges. Achiev Life Sci. Elsevier BV. 2016;10:175\u201386. https:\/\/doi.org\/10.3390\/ijms22020542.","journal-title":"Achiev Life Sci"},{"key":"2569_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2174\/2211536611302010007","volume":"2","author":"S Mi","year":"2013","unstructured":"Mi S, Zhang J, Zhang W, Huang RS. Circulating MicroRNAs as Biomarkers for Inflammatory Diseases. MicroRNA. 2013;2:64\u201372. https:\/\/doi.org\/10.2174\/2211536611302010007.","journal-title":"MicroRNA."},{"key":"2569_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman RC, Farh KKH, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. Cold Spring Harbor Laboratory Press. 2009;19:92\u2013105. https:\/\/doi.org\/10.1101\/gr.082701.108.","journal-title":"Genome Res"},{"key":"2569_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jep.2014.12.001","volume":"161","author":"WF Sun","year":"2015","unstructured":"Sun WF, Zhu MM, Li J, Zhang XX, Liu YW, Wu XR, et al. Effects of Xie-Zhuo-Chu-Bi-Fang on miR-34a and URAT1 and their relationship in hyperuricemic mice. J Ethnopharmacol. Elsevier Ireland Ltd. 2015;161:163\u20139. https:\/\/doi.org\/10.1016\/j.jep.2014.12.001.","journal-title":"J Ethnopharmacol"},{"key":"2569_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbrc.2014.08.068","volume":"452","author":"C Knake","year":"2014","unstructured":"Knake C, Stamp L, Bahn A. Molecular mechanism of an adverse drug-drug interaction of allopurinol and furosemide in gout treatment. Biochem Biophys Res Commun. Elsevier Inc. 2014;452:157\u201362. https:\/\/doi.org\/10.1016\/j.bbrc.2014.08.068.","journal-title":"Biochem Biophys Res Commun"},{"key":"2569_CR14","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.4049\/jimmunol.1201516","volume":"189","author":"F Bauernfeind","year":"2012","unstructured":"Bauernfeind F, Rieger A, Schildberg FA, Knolle PA, Schmid-Burgk JL, Hornung V. NLRP3 inflammasome activity is negatively controlled by miR-223. J Immunol. 2012;189:4175\u201381. https:\/\/doi.org\/10.4049\/jimmunol.1201516.","journal-title":"J Immunol."},{"key":"2569_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"SL Wallace","year":"1977","unstructured":"Wallace SL, Robinson H, Masi AT, Decker JL, Mccarty DJ, Y\u00fc TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20:895\u2013900. https:\/\/doi.org\/10.1002\/art.1780200320.","journal-title":"Arthritis Rheum."},{"key":"2569_CR16","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3390\/jcm8111965","volume":"8","author":"V Horv\u00e1thov\u00e1","year":"2019","unstructured":"Horv\u00e1thov\u00e1 V, Bohat\u00e1 J, Pavl\u00edkov\u00e1 M, Pavelcov\u00e1 K, Pavelka K, \u0160enolt L, et al. Interaction of the p.Q141K variant of the ABCG2 gene with clinical data and cytokine levels in primary hyperuricemia and gout. J Clin Med. 2019;8:1965. https:\/\/doi.org\/10.3390\/jcm8111965.","journal-title":"J Clin Med"},{"key":"2569_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cmet.2012.07.007","volume":"16","author":"AG Lerner","year":"2012","unstructured":"Lerner AG, Upton JP, Praveen PVK, Ghosh R, Nakagawa Y, Igbaria A, et al. IRE1\u03b1 induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab. 2012;16:250\u201364. https:\/\/doi.org\/10.1016\/j.cmet.2012.07.007.","journal-title":"Cell Metab."},{"key":"2569_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12974-018-1077-9","volume":"15","author":"D Chen","year":"2018","unstructured":"Chen D, Dixon BJ, Doycheva DM, Li B, Zhang Y, Hu Q, et al. IRE1\u03b1 inhibition decreased TXNIP\/NLRP3 inflammasome activation through miR-17-5p after neonatal hypoxic-ischemic brain injury in rats. J Neuroinflammation. 2018;15:32. https:\/\/doi.org\/10.1186\/s12974-018-1077-9.","journal-title":"J Neuroinflammation."},{"key":"2569_CR19","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41419-020-03155-9","volume":"11","author":"C Lian","year":"2020","unstructured":"Lian C, Tao T, Su P, Liao Z, Wang X, Lei Y, et al. Targeting miR-18a sensitizes chondrocytes to anticytokine therapy to prevent osteoarthritis progression. Cell Death Dis. 2020;11:947. https:\/\/doi.org\/10.1038\/s41419-020-03155-9.","journal-title":"Cell Death Dis."},{"key":"2569_CR20","doi-asserted-by":"publisher","unstructured":"Alsaleh G, Fran\u04abois A, Philippe L, Gong YZ, Bahram S, Cetin S, et al. MiR-30a-3p negatively regulates BAFF synthesis in systemic sclerosis and rheumatoid arthritis fibroblasts. PLoS One. Public Library of Science. 2014;9. https:\/\/doi.org\/10.1371\/journal.pone.0111266.","DOI":"10.1371\/journal.pone.0111266"},{"key":"2569_CR21","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1016\/j.bbrc.2018.08.049","volume":"503","author":"P Li","year":"2018","unstructured":"Li P, Zhong X, Li J, Liu H, Ma X, He R, et al. MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis. Biochem Biophys Res Commun. 2018;503:2833\u201340. https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.049.","journal-title":"Biochem Biophys Res Commun."},{"key":"2569_CR22","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.2337\/db11-1508","volume":"61","author":"E Arner","year":"2012","unstructured":"Arner E, Mejhert N, Kulyt\u00e9 A, Balwierz PJ, Pachkov M, Cormont M, et al. Adipose tissue MicroRNAs as regulators of CCL2 production in human obesity. Diabetes American Diabetes Association. 2012;61:1986\u201393. https:\/\/doi.org\/10.2337\/db11-1508.","journal-title":"Diabetes"},{"key":"2569_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.bbrc.2013.08.056","volume":"439","author":"S Bandyopadhyay","year":"2013","unstructured":"Bandyopadhyay S, Lane T, Venugopal R, Parthasarathy PT, Cho Y, Galam L, et al. MicroRNA-133a-1 regulates inflammasome activation through uncoupling protein-2. Biochem Biophys Res Commun. NIH Public Access. 2013;439:407\u201312. https:\/\/doi.org\/10.1016\/j.bbrc.2013.08.056.","journal-title":"Biochem Biophys Res Commun"},{"key":"2569_CR24","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00109-013-1037-x","volume":"91","author":"WW Shen","year":"2013","unstructured":"Shen WW, Zeng Z, Zhu WX, Fu GH. MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells. J Mol Med. 2013;91:989\u20131000. https:\/\/doi.org\/10.1007\/s00109-013-1037-x.","journal-title":"J Mol Med."},{"key":"2569_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.bbrc.2019.07.114","volume":"517","author":"Z Zhou","year":"2019","unstructured":"Zhou Z, Dong Y, Zhou H, Liu J, Zhao W. MiR-143-3p directly targets GLUT9 to reduce uric acid reabsorption and inflammatory response of renal tubular epithelial cells. Biochem Biophys Res Commun. 2019;517:413\u201320. https:\/\/doi.org\/10.1016\/j.bbrc.2019.07.114.","journal-title":"Biochem Biophys Res Commun."},{"key":"2569_CR26","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1136\/annrheumdis-2014-205409","volume":"74","author":"N Dalbeth","year":"2015","unstructured":"Dalbeth N, Pool B, Shaw OM, Harper JL, Tan P, Franklin C, et al. Role of miR-146a in regulation of the acute inflammatory response to monosodium urate crystals. Ann Rheum Dis. 2015;74:786\u201390. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205409.","journal-title":"Ann Rheum Dis."},{"key":"2569_CR27","doi-asserted-by":"publisher","first-page":"R88","DOI":"10.1186\/ar4531","volume":"16","author":"HM Jin","year":"2014","unstructured":"Jin HM, Kim TJ, Choi JH, Kim MJ, Cho YN, Nam K. Il, et al. MicroRNA-155 as a proinflammatory regulator via SHIP-1 down-regulation in acute gouty arthritis. Arthritis Res Ther. 2014;16:R88. https:\/\/doi.org\/10.1186\/ar4531.","journal-title":"Arthritis Res Ther."},{"key":"2569_CR28","doi-asserted-by":"publisher","first-page":"44538","DOI":"10.18632\/oncotarget.6253","volume":"6","author":"L Zhao","year":"2015","unstructured":"Zhao L, Ren Y, Tang H, Wang W, He Q, Sun J, et al. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory\/invasive potential. Oncotarget. Impact Journals LLC. 2015;6:44538\u201350. https:\/\/doi.org\/10.18632\/oncotarget.6253.","journal-title":"Oncotarget"},{"key":"2569_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13075-017-1418-6","volume":"19","author":"W Zhou","year":"2017","unstructured":"Zhou W, Wang Y, Wu R, He Y, Su Q, Shi G. MicroRNA-488 and -920 regulate the production of proinflammatory cytokines in acute gouty arthritis. Arthritis Res Ther. 2017;19:203. https:\/\/doi.org\/10.1186\/s13075-017-1418-6.","journal-title":"Arthritis Res Ther."},{"key":"2569_CR30","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1261\/rna.059063.116","volume":"23","author":"MWJ de Ronde","year":"2017","unstructured":"de Ronde MWJ, Ruijter JM, Lanfear D, Bayes-Genis A, Kok MGM, Creemers EE, et al. Practical data handling pipeline improves performance of qPCR-based circulating miRNA measurements. RNA. 2017;23:811\u201321. https:\/\/doi.org\/10.1261\/rna.059063.116.","journal-title":"RNA."},{"key":"2569_CR31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fgene.2013.00094","volume":"4","author":"MB Kirschner","year":"2013","unstructured":"Kirschner MB, Edelman JJB, Kao SCH, Vallely MP, Van Zandwijk N, Reid G. The impact of hemolysis on cell-free microRNA biomarkers. Front Genet. 2013;4:94. https:\/\/doi.org\/10.3389\/fgene.2013.00094.","journal-title":"Front Genet."},{"key":"2569_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bcp.2016.02.011","volume":"104","author":"A Ripperger","year":"2016","unstructured":"Ripperger A, Benndorf RA. The C421A (Q141K) polymorphism enhances the 3\u2032-untranslated region (3\u2032-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2. Biochem Pharmacol. 2016;104:139\u201347. https:\/\/doi.org\/10.1016\/j.bcp.2016.02.011.","journal-title":"Biochem Pharmacol."},{"key":"2569_CR33","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1159\/000430176","volume":"36","author":"Y Wang","year":"2015","unstructured":"Wang Y, Xu D, Wang B, Hou X. Could microRNAs be regulators of gout pathogenesis? Cell Physiol Biochem. 2015;36:2085\u201392. https:\/\/doi.org\/10.1159\/000430176.","journal-title":"Cell Physiol Biochem."},{"key":"2569_CR34","doi-asserted-by":"publisher","first-page":"11193","DOI":"10.1073\/pnas.1019536108","volume":"108","author":"M Kurowska-Stolarska","year":"2011","unstructured":"Kurowska-Stolarska M, Alivernini S, Ballantine LE, Asquith DL, Millar NL, Gilchrist DS, et al. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A. 2011;108:11193\u20138. https:\/\/doi.org\/10.1073\/pnas.1019536108.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2569_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13075-018-1550-y","volume":"20","author":"Q Yang","year":"2018","unstructured":"Yang Q, Zhang Q, Qing Y, Zhou L, Mi Q, Zhou J. miR-155 is dispensable in monosodium urate-induced gouty inflammation in mice. Arthritis Res Ther. 2018;20:177. https:\/\/doi.org\/10.1186\/s13075-018-1550-y.","journal-title":"Arthritis Res Ther"},{"key":"2569_CR36","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/1756-185X.13338","volume":"21","author":"SC Bae","year":"2018","unstructured":"Bae SC, Lee YH. MiR-146a levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis. Int J Rheum Dis. 2018;21:1335\u201342. https:\/\/doi.org\/10.1111\/1756-185X.13338.","journal-title":"Int J Rheum Dis."},{"key":"2569_CR37","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nature03552","volume":"435","author":"L He","year":"2005","unstructured":"He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, et al. A microRNA polycistron as a potential human oncogene. Nature. 2005;435:828\u201333. https:\/\/doi.org\/10.1038\/nature03552.","journal-title":"Nature."},{"key":"2569_CR38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jfma.2018.04.013","volume":"118","author":"G Kuo","year":"2019","unstructured":"Kuo G, Wu CY, Yang HY. MiR-17-92 cluster and immunity. J Formos Med Assoc. 2019;118:2\u20136. https:\/\/doi.org\/10.1016\/j.jfma.2018.04.013.","journal-title":"J Formos Med Assoc."},{"key":"2569_CR39","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pbiomolbio.2019.05.004","volume":"150","author":"P Zamani","year":"2020","unstructured":"Zamani P, Oskuee RK, Atkin SL, Navashenaq JG, Sahebkar A. MicroRNAs as important regulators of the NLRP3 inflammasome. Prog Biophys Mol Biol. 2020;150:50\u201361. https:\/\/doi.org\/10.1016\/j.pbiomolbio.2019.05.004.","journal-title":"Prog Biophys Mol Biol."},{"key":"2569_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008318","volume":"15","author":"S Lang","year":"2019","unstructured":"Lang S, Hilsabeck TA, Wilson KA, Sharma A, Bose N, Brackman DJ, et al. A conserved role of the insulin-like signaling pathway in diet-dependent uric acidpathologies in Drosophila melanogaster. PLoS Genet. 2019;15:e1008318. https:\/\/doi.org\/10.1371\/journal.pgen.1008318.","journal-title":"PLoS Genet."},{"key":"2569_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5414\/cp201425","volume":"49","author":"C Okuda","year":"2011","unstructured":"Okuda C, Koyama H, Tsutsumi Z, Yamamoto A, Kurajoh M, Moriwaki Y, et al. Serum CRP in patients with gout and effects of benzbromarone. Int J Clin Pharmacol Ther. Int J Clin Pharmacol Ther. 2011;49:191\u20137. https:\/\/doi.org\/10.5414\/cp201425.","journal-title":"Int J Clin Pharmacol Ther."},{"key":"2569_CR42","doi-asserted-by":"publisher","first-page":"6345284","DOI":"10.1155\/2018\/6345284","volume":"2018","author":"Q Su","year":"2018","unstructured":"Su Q, Yang H, Li L. Circulating miRNA-155 as a potential biomarker for coronary slow flow. Dis Markers. 2018;2018:6345284. https:\/\/doi.org\/10.1155\/2018\/6345284.","journal-title":"Dis Markers."},{"key":"2569_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050046","volume":"7","author":"E Krishnan","year":"2012","unstructured":"Krishnan E. Reduced Glomerular Function and Prevalence of Gout: NHANES 2009-10. PLoS One. 2012;7:e50046. https:\/\/doi.org\/10.1371\/journal.pone.0050046.","journal-title":"PLoS One."},{"key":"2569_CR44","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","volume":"41","author":"J Kanellis","year":"2003","unstructured":"Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41:1287\u201393. https:\/\/doi.org\/10.1161\/01.HYP.0000072820.07472.3B.","journal-title":"Hypertension."},{"key":"2569_CR45","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/rheumatology\/kes326","volume":"52","author":"R Grainger","year":"2013","unstructured":"Grainger R, McLaughlin RJ, Harrison AA, Harper JL. Hyperuricaemia elevates circulating CCL2 levels and primes monocyte trafficking in subjects with inter-critical gout. Rheumatol (Oxford). 2013;52:1018\u201321. https:\/\/doi.org\/10.1093\/rheumatology\/kes326.","journal-title":"Rheumatol (Oxford)."},{"key":"2569_CR46","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.prp.2018.05.012","volume":"214","author":"Q Ding","year":"2018","unstructured":"Ding Q, Shen L, Nie X, Lu B, Pan X, Su Z, et al. MiR-223-3p overexpression inhibits cell proliferation and migration by regulating inflammation-associated cytokines in glioblastomas. Pathol Res Pract. Elsevier. 2018;214:1330\u20139. https:\/\/doi.org\/10.1016\/j.prp.2018.05.012.","journal-title":"Pathol Res Pract"},{"key":"2569_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-016-1158-z","volume":"18","author":"Y Wang","year":"2016","unstructured":"Wang Y, Liang J, Qin H, Ge Y, Du J, Lin J, et al. Elevated expression of miR-142-3p is related to the pro-inflammatory function of monocyte-derived dendritic cells in SLE. Arthritis Res Ther. BioMed Central Ltd. 2016;18:1\u201311. https:\/\/doi.org\/10.1186\/s13075-016-1158-z.","journal-title":"Arthritis Res Ther"},{"key":"2569_CR48","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1002\/art.24475","volume":"60","author":"Y Nakamachi","year":"2009","unstructured":"Nakamachi Y, Kawano S, Takenokuchi M, Nishimura K, Sakai Y, Chin T, et al. MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum. 2009;60:1294\u2013304. https:\/\/doi.org\/10.1002\/art.24475.","journal-title":"Arthritis Rheum."},{"key":"2569_CR49","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3390\/cells9071669","volume":"9","author":"M-F Liao","year":"2020","unstructured":"Liao M-F, Hsu J-L, Lu K-T, Chao P-K, Cheng M-Y, Hsu H-C, et al. Granulocyte Colony Stimulating Factor (GCSF) Can Attenuate Neuropathic Pain by Suppressing Monocyte Chemoattractant Protein-1 (MCP-1) Expression, through Upregulating the Early MicroRNA-122 Expression in the Dorsal Root Ganglia. Cells. 2020;9:1669. https:\/\/doi.org\/10.3390\/cells9071669.","journal-title":"Cells."},{"key":"2569_CR50","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/13102818.2020.1738955","volume":"34","author":"F Zhu","year":"2020","unstructured":"Zhu F, Yin J, Li J, Xue J. MicroRNA-421 affects the chemotaxis of monocytes via MCP-1, and regulates the local immune responses in injured cartilage site of elbow joint of upper limbs. Biotechnol Biotechnol Equip. 2020;34:294\u2013302. https:\/\/doi.org\/10.1080\/13102818.2020.1738955.","journal-title":"Biotechnol Biotechnol Equip"},{"key":"2569_CR51","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3389\/fphar.2018.00900","volume":"9","author":"Z Yang","year":"2018","unstructured":"Yang Z, Guo Z, Dong J, Sheng S, Wang Y, Yu L, et al. miR-374a regulates inflammatory response in diabetic nephropathy by targeting MCP-1 expression. Front Pharmacol. 2018;9:900. https:\/\/doi.org\/10.3389\/fphar.2018.00900.","journal-title":"Front Pharmacol"},{"key":"2569_CR52","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1158\/1535-7163.1577.3.12","volume":"3","author":"PLR Ee","year":"2004","unstructured":"Ee PLR, He X, Ross DD, Beck WT. Modulation of breast cancer resistance protein (BCRP\/ABCG2) gene expression using RNA interference. Mol Cancer Ther. 2004;3:1577\u201383 PMID: 15634651.","journal-title":"Mol Cancer Ther."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02569-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-021-02569-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02569-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T15:57:30Z","timestamp":1672761450000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-021-02569-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,10]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2569"],"URL":"https:\/\/doi.org\/10.1186\/s13075-021-02569-w","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,10]]},"assertion":[{"value":"22 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}